| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |